Search Results - "Sheikh, Gabriel"

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [¹⁸F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?

Authors: Novruzov, Emil Sheikh, Gabriel Feisthauer, Anna et al.

Source: EJNMMI Research. 3/3/2026, Vol. 16 Issue 1, p1-10. 10p.

Cardiac risk in recovered Covid-19 patients evaluated by 123 I-mIBG.

Authors: Liebich, Alessandro Sheikh, Gabriel Bundschuh, Ralph. A. et al.

Source: Scientific Reports. 5/23/2025, Vol. 15 Issue 1, p1-6. 6p.

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0.

Authors: Novruzov, Emil Sheikh, Gabriel T. Mamlins, Eduards et al.

Source: Journal of Nuclear Medicine. Aug2025, Vol. 66 Issue 8, p1245-1251. 7p.

FAP-Directed Imaging and Therapy in Head and Neck Cancer of Unknown Primary.

Authors: Kunte, Sophie C. Sheikh, Gabriel T. Giesel, Frederik L. et al.

Source: Cancers. Jul2025, Vol. 17 Issue 13, p2205. 9p.

[¹⁸F]F-FAPI-74 PET/CT for gonadal and extragonadal germ cell Tumors: a pilot study.

Authors: Kidess, Marc Siegmund, Sophie C. Unterrainer, Lena M. et al.

Source: EJNMMI Research. 1/2/2026, Vol. 16 Issue 1, p1-6. 6p.

Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.

Authors: Voltin, Conrad-Amadeus Flossdorf, Sarah Kurch, Lars et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p871-877. 7p.

PSMA PET–Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.

Authors: Moar, Erik F. Keilholz, Michael Sheikh, Gabriel T. et al.

Source: Journal of Nuclear Medicine. Mar2026, Vol. 67 Issue 3, p404-409. 6p.

RECIP 1.0 + PSA for response assessment in mCRPC patients treated with ²²⁵Ac / ¹⁷⁷Lu PSMA combination therapy.

Authors: Sheikh, Gabriel T. Delker, Astrid Zacherl, Mathias J. et al.

Source: EJNMMI Research. 3/4/2025, Vol. 15 Issue 1, p1-9. 9p.

Investigation of iterative deconvolution in ¹⁷⁷Lu-SPECT imaging for lesion dosimetry.

Authors: Ells, Zachary Liubchenko, Grigory Rumiantcev, Mikhail et al.

Source: EJNMMI Physics. 4/13/2026, Vol. 13 Issue 1, p1-15. 15p.

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target.

Authors: Şen, Feyza Sheikh, Gabriel T. von Hinten, Johannes et al.

Source: Cancers. Jul2023, Vol. 15 Issue 14, p3595. 10p.

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.

Authors: Novruzov, Emil Mamlins, Eduards Widjaja, Liam et al.

Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p687-692. 6p.

Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancer.

Authors: Trapp, Christian Brose, Sarah Frederike Keilholz, Michael et al.

Source: EJNMMI Research. 6/23/2026, Vol. 16 Issue 1, p1-12. 12p.

Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.

Authors: Unterrainer, Lena M. De Leiris, Nicolas Unterrainer, Marcus et al.

Source: Journal of Nuclear Medicine. Jul2025, Vol. 66 Issue 7, p1054-1060. 7p.

Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.

Authors: Herr, Felix L. Dascalescu, Christian Fusch, Victoria et al.

Source: EJNMMI Research. 8/21/2025, Vol. 15 Issue 1, p1-7. 7p.

Feasibility of different lymph node metastases delineation approaches in [¹⁸F]SiTATE PET/CT imaging in NET patients.

Authors: Siegmund, Sophie Carina Schöll, Magdalena Wenter, Vera U. et al.

Source: EJNMMI Reports. 10/30/2025, Vol. 9 Issue 1, p1-10. 10p.

ESR Essentials: role of PET/CT in neuroendocrine tumors—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging.

Authors: Ebner, Ricarda Sheikh, Gabriel T. Brendel, Matthias et al.

Source: European Radiology. Apr2025, Vol. 35 Issue 4, p1903-1912. 10p.

Subjects: Positron emission tomography computed tomography, Somatostatin receptors, Neuroendocrine tumors, Peptide receptors, Neuroendocrine system

ESR Essentials: staging and restaging with FDG-PET/CT in oncology—practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging.

Authors: Ebner, Ricarda Sheikh, Gabriel T. Brendel, Matthias et al.

Source: European Radiology. Apr2025, Vol. 35 Issue 4, p1894-1902. 9p.

Subjects: Magnetic resonance imaging, Positron emission tomography, Medical sciences, Cancer chemotherapy, Physicians

PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [²²⁵Ac]Ac-PSMA Radiopharmaceutical Therapy.

Authors: Widjaja, Liam Siegmund, Sophie C. Gildehaus, Franz J. et al.

Source: Journal of Nuclear Medicine. Apr2026, Vol. 67 Issue 4, p568-575. 8p.

Comparison of scatter and partial volume correction techniques for quantitative SPECT imaging of ²²⁵Ac.

Authors: Liubchenko, Grigory Böning, Guido Rumiantcev, Mikhail et al.

Source: EJNMMI Physics. 10/2/2025, Vol. 12 Issue 1, p1-18. 18p.

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [¹⁸F]SiTATE – first clinical experiences.

Authors: Kunte, Sophie C. Wenter, Vera Toms, Johannes et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p900-912. 13p.